Published in Cytokine on August 01, 2000
Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet (2007) 1.68
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors. Mol Cancer Ther (2009) 1.57
Genetic susceptibility to retinopathy of prematurity: the evidence from clinical and experimental animal studies. Br J Ophthalmol (2007) 1.56
Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease. J Clin Pathol (2003) 1.47
Molecular biology of lung cancer: clinical implications. Clin Chest Med (2011) 1.47
Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol (2011) 1.44
Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy. Mol Vis (2008) 1.39
A systematic meta-analysis of genetic association studies for diabetic retinopathy. Diabetes (2009) 1.33
Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology. Cancer Prev Res (Phila) (2009) 1.32
Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax (2006) 1.26
Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS. Thorax (2007) 1.21
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib. Br J Cancer (2012) 1.21
Role of genetic polymorphisms in tumour angiogenesis. Br J Cancer (2002) 1.18
Vascular endothelial growth factor in heart failure. Nat Rev Cardiol (2013) 1.16
Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab. Int J Colorectal Dis (2010) 1.07
The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Hum Genet (2009) 1.06
VEGF polymorphisms and severity of atherosclerosis. J Med Genet (2005) 1.05
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03
Genetic susceptibility to advanced retinopathy of prematurity (ROP). J Biomed Sci (2010) 1.03
Polymorphisms in the vascular endothelial growth factor gene and the risk of diabetic retinopathy in Chinese patients with type 2 diabetes. Mol Vis (2011) 1.01
Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis (2008) 1.01
Genetic contributions to the development of retinopathy of prematurity. Pediatr Res (2009) 1.01
Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol (2007) 1.01
Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients. Br J Clin Pharmacol (2011) 0.97
Vascular endothelial growth factor polymorphisms and esophageal cancer prognosis. Clin Cancer Res (2009) 0.97
Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer. BMC Cancer (2011) 0.94
Pancreatic duct cells in human islet cell preparations are a source of angiogenic cytokines interleukin-8 and vascular endothelial growth factor. Diabetes (2008) 0.94
Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy. BMC Cancer (2010) 0.93
An association between vascular endothelial growth factor gene promoter polymorphisms and diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol (2007) 0.92
Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells: role of vascular endothelial growth factor genotype. Am J Respir Cell Mol Biol (2005) 0.92
Angiogenesis and antiangiogenic agents in cervical cancer. Onco Targets Ther (2014) 0.91
The importance of -460 C/T and +405 G/C single nucleotide polymorphisms to the function of vascular endothelial growth factor A in colorectal cancer. J Cancer Res Clin Oncol (2009) 0.91
Lack of association of the VEGF gene promoter (-634 G-->C and -460 C-->T) polymorphism and the risk of advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol (2006) 0.90
Discovery and functional assessment of gene variants in the vascular endothelial growth factor pathway. Hum Mutat (2013) 0.89
Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci (2008) 0.89
Vascular endothelial growth factor gene polymorphisms and renal cell carcinoma: A systematic review and meta-analysis. Oncol Lett (2013) 0.88
Vascular endothelial growth factor A polymorphisms and age-related macular degeneration: a systematic review and meta-analysis. Mol Vis (2013) 0.88
Association between vascular endothelial growth factor gene polymorphisms and bladder cancer risk. Mol Clin Oncol (2014) 0.87
The role of vascular endothelial growth factor a polymorphisms in breast cancer. Int J Mol Sci (2012) 0.87
Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma. PLoS One (2014) 0.86
VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population. Int J Colorectal Dis (2008) 0.86
Innate immunity and genetic determinants of urinary tract infection susceptibility. Curr Opin Infect Dis (2015) 0.86
Vascular endothelial growth factor genetic variability and coronary artery disease in Brazilian population. Heart Vessels (2008) 0.85
VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration. Jpn J Ophthalmol (2011) 0.85
Increase levels of apo-A1 and apo B are associated in knee osteoarthritis: lack of association with VEGF-460 T/C and +405 C/G polymorphisms. Rheumatol Int (2008) 0.84
The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer. BMC Gastroenterol (2009) 0.84
Vascular endothelial growth factor (VEGF-634G/C) polymorphism and retinopathy of prematurity: a meta-analysis. Saudi J Ophthalmol (2014) 0.84
Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy. Cancer Sci (2012) 0.84
Oesophageal squamous cell carcinoma in high-risk Chinese populations: Possible role for vascular epithelial growth factor A. Eur J Cancer (2014) 0.84
VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide. Br J Cancer (2013) 0.84
Role of vascular endothelial growth factor polymorphisms (-2578C>A, -460 T>C, -1154G>A, +405G>C and +936C>T) in endometriosis: a case-control study with Brazilians. BMC Womens Health (2014) 0.84
Antagonising angiogenesis in rheumatoid arthritis. Ann Rheum Dis (2001) 0.83
Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease. Urol Res (2003) 0.83
Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer. Yonsei Med J (2008) 0.83
Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients. Ann Rheum Dis (2006) 0.83
Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia. PLoS One (2014) 0.83
Circulating vascular endothelial growth factor concentrations in patients with postmenopausal osteoporosis. Arch Med Sci (2013) 0.83
Genetics of sarcoidosis: candidate genes and genome scans. Proc Am Thorac Soc (2007) 0.82
Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis. Oncol Rep (2012) 0.82
The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women. J Assist Reprod Genet (2014) 0.82
The relationship of vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer. BMC Cancer (2013) 0.82
Gene expression analysis of VEGF and its receptors and assessment of its serum level in unexplained recurrent spontaneous abortion. Cell J (2015) 0.82
Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis. Neurogenetics (2005) 0.82
Personalizing colon cancer therapeutics: targeting old and new mechanisms of action. Pharmaceuticals (Basel) (2013) 0.81
A pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer. Carcinogenesis (2014) 0.81
Association of VEGF genetic polymorphisms with the clinical characteristics of non-Hodgkin's lymphoma. J Cancer Res Clin Oncol (2009) 0.81
VEGF and bFGF gene polymorphisms in patients with non-Hodgkin's lymphoma. Biomed Res Int (2013) 0.81
Association of vascular endothelial growth factor (VEGF) +405 g>c polymorphism with endometriosis in an Iranian population. J Reprod Infertil (2010) 0.81
Angiogenesis in inflammatory joint disease: a target for therapeutic intervention. Clin Exp Immunol (2000) 0.81
Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD). BMC Pulm Med (2012) 0.81
Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis. Clin Cosmet Investig Dermatol (2013) 0.81
Polymorphisms of vascular endothelial growth factor on prognosis in osteosarcoma patients. Pak J Med Sci (2014) 0.81
Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformation. PLoS One (2009) 0.80
Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer. Int J Clin Oncol (2012) 0.80
Association of 18bp insertion/deletion polymorphism, at -2549 position of VEGF gene, with diabetic nephropathy in type 2 diabetes mellitus patients of North Indian population. J Diabetes Metab Disord (2015) 0.80
Vascular endothelial growth factor +936C/T polymorphism and gastric cancer risk: A meta-analysis. Exp Ther Med (2011) 0.80
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy. Oncotarget (2015) 0.80
Meta-analysis of the association between VEGF-634 G>C and risk of malignancy based on 23 case-control studies. J Cancer Res Clin Oncol (2010) 0.80
Correlation of genetic polymorphism of vascular endothelial growth factor gene with susceptibility to lung cancer. Cancer Gene Ther (2015) 0.80
Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population. Biomark Res (2014) 0.80
Allelic Interaction between CRELD1 and VEGFA in the Pathogenesis of Cardiac Atrioventricular Septal Defects. AIMS Genet (2014) 0.80
Diabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomics. Pharmgenomics Pers Med (2014) 0.80
Investigation on the role of VEGF gene polymorphisms in the risk of osteosarcoma. Pak J Med Sci (2015) 0.79
Influence of CHIEF pathway genes on gene expression: a pathway approach to functionality. Int J Mol Epidemiol Genet (2014) 0.79
VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese. Int J Med Sci (2008) 0.79
Association of VEGF genetic polymorphisms with recurrent spontaneous abortion risk: a systematic review and meta-analysis. PLoS One (2015) 0.78
The association between vascular endothelial growth factor gene polymorphisms and stroke: a meta-analysis. Brain Behav (2016) 0.78
Association of a vascular endothelial growth factor polymorphism with the development of bronchopulmonary dysplasia in Japanese premature newborns. Sci Rep (2014) 0.78
Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease. J Inherit Metab Dis (2015) 0.78
Four polymorphisms of VEGF (+405C>G, -460T>C, -2578C>A, and -1154G>A) in susceptibility to psoriasis: a meta-analysis. DNA Cell Biol (2014) 0.78
Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer. J Exp Clin Cancer Res (2009) 0.78
Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma. PLoS One (2015) 0.78
Lack of association of the vascular endothelial growth factor gene polymorphisms with Kawasaki disease in Taiwanese children. J Clin Immunol (2008) 0.78
TLR-4 and VEGF polymorphisms in chronic periaortitis. PLoS One (2013) 0.78
Prevalence of +405G>C,-1154G>A Vascular Endothelial Growth Factor Polymorphism in Breast Cancer. Indian J Clin Biochem (2013) 0.78
Four common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis. PLoS One (2013) 0.78
Predictive value of vascular endothelial growth factor polymorphisms on the clinical outcome of renal cell carcinoma patients. Oncol Lett (2014) 0.78
The prognostic value of haplotypes in the vascular endothelial growth factor a gene in colorectal cancer. Cancers (Basel) (2010) 0.78
Encapsulating peritoneal sclerosis in children. Pediatr Nephrol (2013) 0.78
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc Natl Acad Sci U S A (2007) 3.60
Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J (1996) 3.41
Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax (2004) 2.45
Structural basis for recognition of the intron branch site RNA by splicing factor 1. Science (2001) 2.35
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int (2001) 1.99
Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease. Clin Nephrol (1989) 1.63
The three-dimensional structure of the HRDC domain and implications for the Werner and Bloom syndrome proteins. Structure (1999) 1.57
Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 A resolution. Nature (1995) 1.55
Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) (1998) 1.46
Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid. Clin Exp Immunol (2000) 1.16
Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology (2001) 1.15
Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): specific up-regulation by tumour necrosis factor-alpha (TNF-alpha) in synovial fluid. Clin Exp Immunol (1999) 1.14
Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine (1998) 1.10
Intermolecular interactions of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase. J Biol Chem (1999) 1.07
Glomerular basement membrane proteoglycans are derived from a large precursor. J Cell Biol (1988) 1.04
Doctors as well as patients need education to ensure adherence to treatment regiments. BMJ (1997) 1.00
Sequential study of the IgA system in relapsing IgA nephropathy. Kidney Int (1986) 0.98
Modulation of cellular immune function by cyclophosphamide in children with minimal-change nephropathy. N Engl J Med (1984) 0.98
Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. J Clin Pathol (1999) 0.95
Mast cells: the forgotten cells of renal fibrosis. J Clin Pathol (2000) 0.94
Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy. Kidney Int (1995) 0.91
An association between antibodies specific for endothelial cells and renal transplant failure. Transpl Immunol (1998) 0.90
A genetic marker of high TNF-alpha production in heart transplant recipients. Transplantation (1995) 0.88
Plasma TGF beta in systemic sclerosis: a cross-sectional study. Ann Rheum Dis (1994) 0.88
A peroxidase-linked enzyme immunoassay for tumour necrosis factor alpha utilising alternative colorimetric or chemilumimetric substrates. J Immunol Methods (1992) 0.86
Early cytokine response to multiple injury. Injury (1993) 0.85
Transforming growth factor beta 1 in renal allograft recipients. Transplantation (1994) 0.84
Autoimmunity in IgA nephropathy. Lancet (1988) 0.84
Plasma transforming growth factor beta(1) and platelet activation: implications for studies in transplant recipients. Nephrol Dial Transplant (2001) 0.84
Investigative techniques and renal parenchymal damage in children with spina bifida. Eur J Pediatr Surg (1994) 0.84
Serum and urine IL-6 and TNF-alpha in renal transplant recipients with graft dysfunction. Transplantation (1993) 0.83
Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate. Biochem J (1989) 0.83
Hemolytic uremic syndrome secondary to the treatment of acute lymphoblastic leukemia. J Pediatr Hematol Oncol (2000) 0.83
Investigation of IgG4 levels in atopic patients using a competitive inhibition assay employing biotinylated IgG4 myeloma and avidin peroxidase. J Immunol Methods (1986) 0.82
Refinement of the protein backbone angle psi in NMR structure calculations. J Biomol NMR (2000) 0.82
Angiogenesis in inflammatory joint disease: a target for therapeutic intervention. Clin Exp Immunol (2000) 0.81
Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome. Kidney Int (1999) 0.81
Structural and biochemical evaluation of the interaction of the phosphatidylinositol 3-kinase p85alpha Src homology 2 domains with phosphoinositides and inositol polyphosphates. J Biol Chem (1999) 0.81
Serum cytokines in human heart transplant recipients. Is there a relationship to rejection? Transplantation (1996) 0.80
Response of circulating immune complexes to food challenge in relapsing IgA nephropathy. Pediatr Nephrol (1987) 0.80
IgG subclass distribution of antinative type II collagen and antidenatured type II collagen antibodies in patients with rheumatoid arthritis. J Rheumatol (1988) 0.80
Impaired IgG response to tetanus toxoid in human membranous nephropathy: association with HLA-DR3. Clin Exp Immunol (1986) 0.80
Fine-scale genetic structuring in a natural population of European wild rabbits (Oryctolagus cuniculus). Mol Ecol (1999) 0.80
Connective-tissue glycoconjugates of bovine tendon and skin. Biochem Soc Trans (1977) 0.79
Expression of cytokine messenger RNA after heart transplantation: relationship with rejection and serum cytokines. Transplantation (1996) 0.79
Seizures following renal transplantation in childhood. Pediatr Nephrol (1999) 0.79
A comparison of double-cuffed with single-cuffed Tenckhoff catheters in the prevention of infection in pediatric patients. Adv Perit Dial (1997) 0.79
The identification of allo- and auto-lymphocytotoxic antibodies in serum, in the presence of rabbit antithymocyte globulin. Tissue Antigens (1988) 0.78
Comparison of CRM197, diphtheria toxoid and tetanus toxoid as protein carriers for meningococcal glycoconjugate vaccines. Vaccine (2013) 0.78
Dramatic changes of sulfated proteoglycans composition in a tumorigenic SV-40-transformed renal proximal-tubule cell line. J Biol Chem (1992) 0.77
The temporal relationship between urinary C5b-9 and C3dg and clinical parameters in human membranous nephropathy. Nephrol Dial Transplant (1993) 0.77
Is persistent TGFbeta1 expression the mechanism responsible for chronic renal allograft loss? Nephrol Dial Transplant (1998) 0.77
Do children with diffuse mesangial sclerosis in association with mutations of the Wilm's tumour suppressor gene (WT1) require bilateral nephrectomy? Pediatr Nephrol (1995) 0.76
Detection of anti-epithelial cell antibodies in association with pediatric renal transplant failure using a novel microcytotoxicity assay. Tissue Antigens (1991) 0.76
Serum cytokine levels in patients undergoing bone marrow transplantation. Bone Marrow Transplant (1993) 0.75
Renal cancer in renal transplant paediatric recipients. Transplantation (2000) 0.75
Strategies for meaningful measurement of circulating levels of transforming growth factor beta1 in clinical samples. Transplantation (2001) 0.75
Coupling of mono- and polyamino ligands to solid phases by nucleophilic attack on coupling groups that may be spontaneously hydrolysed. J Chromatogr (1990) 0.75
IgE in milk allergy. Postgrad Med J (1975) 0.75
Th1 and Th2 cytokine gene expression in human renal allografts. Transplant Proc (1995) 0.75
Repeat testing is essential when estimating chronic kidney disease prevalence and associated cardiovascular risk. QJM (2011) 0.75
Major influence of cell differentiation status on characteristics of proteoglycans synthesized by cultured rabbit renal proximal tubule cells: role of insulin and dexamethasone. J Cell Physiol (1993) 0.75
C-reactive protein levels in serum: a rapid enzyme immunoassay. Med Lab Sci (1991) 0.75
Membranous nephropathy: monoclonal IgG and nephrotic-range proteinuria in a renal transplant recipient. Nephrol Dial Transplant (1989) 0.75
Living-related donation: do professional opinions influence parent decision making? Pediatr Nephrol (1999) 0.75
Antithymocyte globulin preparations after heart transplantation. Cytokine responses in vivo and in vitro. Transplantation (1995) 0.75
Expression and characterisation of a very-late antigen-4 (alpha 4 beta 1) integrin-binding fragment of vascular cell-adhesion molecule-1. Eur J Biochem (1994) 0.75
Outcome of pediatric cadaveric renal transplantation: a 10 year study. Kidney Int Suppl (1996) 0.75
Macroscopic haematuria following immunisation with tetanus toxoid and oral polio vaccine. Eur J Pediatr (1997) 0.75
Serum soluble adhesion molecules and cytokines in cardiac allograft rejection. The Manchester Transplant Cytokine Group. Transpl Immunol (1994) 0.75
Clinical aspects of C3dg and C5b-9 in human membranous nephropathy. Nephrol Dial Transplant (1992) 0.75
Minimal change nephropathy and focal segmental glomerulosclerosis. Kidney Int Suppl (1997) 0.75